Skip to main content
Retour
Watch Compare

Nuvectis Pharma, Inc.

Qualité des données : 83%
NVCT
NASDAQ Manufacturing Chemicals
8,22 €
▲ 0,06 € (0,74%)
Cap. Boursière: 216,17 M
Prix
8,16 €
Cap. Boursière
216,17 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -16,01 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-129,36%
En dessous de la moyenne du secteur (-53,58%)
ROIC-106,57%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio3,07
Interest CoverageN/A

Valorisation

PE (TTM)
-8,18
En dessous de la moyenne du secteur (-1,48)
P/B Ratio9,00
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -8,2 -1,5
P/B 9,0 1,6
ROE % -129,4 -53,6
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

5 analystes
Buy
Actuel
8,22 €
+104.4%
Objectif
16,80 €
10,00 €
18,00 €
20,00 €
Prévisions
BPA Prévisionnel -1,32 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -1,32 €
-1,40 € – -1,16 €
 0,0 5
FY2026 -1,27 €
-1,35 € – -1,20 €
 0,0 5

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,31 € -0,31 € -0,7%
Q32025 -0,25 € -0,44 € -76,0%
Q22025 -0,25 € -0,30 € -19,2%
Q12025 -0,25 € -0,27 € -6,3%

ETFs Holding This Stock

IRSIX IRSIX
0,00% weight
IIRSX IIRSX
0,00% weight
IRCIX IRCIX
0,00% weight
VVICX VVICX
0,00% weight
IRSSX IRSSX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -26,44 M
ROE -129,36% ROA -84,49%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -16,01 M
ROIC -106,57% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,07
Interest Coverage N/A Asset Turnover N/A
Working Capital 24,01 M Tangible Book Value 24,01 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,18 Forward P/E N/A
P/B Ratio 9,00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7,41%
Market Cap 216,17 M Enterprise Value 180,73 M
Per Share
EPS (Diluted TTM) -1,32 Revenue / Share N/A
FCF / Share -0,60 OCF / Share -0,60
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 60,54%
SBC-Adj. FCF -21,83 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -26,44 M -19,00 M -22,26 M -19,09 M
EPS (Diluted) -1,32 -1,11 -1,43 -1,51
Gross Profit — — — —
Operating Income -27,57 M -19,85 M -22,90 M -19,23 M
EBITDA — — — —
R&D Expenses 18,15 M 12,92 M 15,38 M 13,23 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense — — — —
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 31,71 M 18,61 M 19,19 M 20,41 M
Total Liabilities 13,30 M 8,89 M 6,98 M 6,19 M
Shareholders' Equity 18,41 M 9,71 M 12,20 M 14,22 M
Total Debt — — — —
Cash & Equivalents 31,63 M 18,53 M 19,13 M 19,99 M
Current Assets 31,71 M 18,61 M 19,19 M 20,41 M
Current Liabilities 13,30 M 8,89 M 6,98 M 6,19 M